Drug Development of Small-Molecule Inhibitors of AD-Relevant Kinases as Novel Perspective Multitargeted Approach

E-ISSN： 1875-5828|13|12|1330-1336

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.13, Iss.12, 2016-12, pp. : 1330-1336

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small molecule inhibitors of Aβ assembly

By Levine Harry

Amyloid: The Journal of Protein Folding Disorders, Vol. 14, Iss. 3, 2007-01 ,pp. : 185-197

Informa Healthcare

Access to resources Recommend Favorite

Identification of Small Molecule Inhibitors of Tau Aggregation by Targeting Monomeric Tau As a Potential Therapeutic Approach for Tauopathies

Current Alzheimer Research, Vol. 12, Iss. 9, 2015-11 ,pp. : 814-828

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation and Detection of Tau Aggregation with Small-Molecule Ligands

Current Alzheimer Research, Vol. 6, Iss. 5, 2009-01 ,pp. : 409-414

Bentham Science Publishers

Access to resources Recommend Favorite

Memapsin 2 (Beta-Secretase) Inhibitors: Drug Development

Current Alzheimer Research, Vol. 5, Iss. 2, 2008-04 ,pp. : 121-131

Bentham Science Publishers

Access to resources Recommend Favorite

Development of the Lurian Approach: A Cultural Neurolinguistic Perspective

By Kotik-Friedgut Bella

Neuropsychology Review, Vol. 16, Iss. 1, 2006-03 ,pp. : 43-52

Springer Publishing Company

Access to resources Recommend Favorite